Clinical Trial Update: Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of eltrombopag to initiate and maintain interferon antiviral therapy for patients with chronic hepatitis C-related liver disease has completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Promacta (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2012-05-17